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VII ABSTRAK 
 
Pengeluaran cecair dari pleura adalah rawatan pilihan untuk pesakit yang mempunyai 
simptom sukar bernafas disebabkan oleh penyakit malignant pleural effusion. Kebiasaannya, 
rawatan untuk pleural effusion adalah dengan memasukkan tiub bersaiz besar ke dalam ruang 
selaput paru-paru untuk mengeluarkan cecair yang terkumpul sebelum melakukan 
‘pleurodesis’ iaitu proses perlekatan selaput paru-paru menggunakan ubat. Tujuan kajian 
prospektif ini adalah untuk menilai keberkesanan proses perlekatan selaput paru-paru dengan 
menggunakan tiub bersaiz kecil (Mar Flow® CH12 ‘pigtail catheter’) dan bleomycin untuk 
pesakit yang mengalami penyakit barah paru-paru berair. Proses perlekatan paru-paru dengan 
bleomycin dilakukan dalam tempoh dua puluh empat jam selepas tiub ‘pigtail’ dimasukkan. 
Pesakit akan dinilai semula pada empat minggu selepas proses perlekatan pleura dijalankan 
berserta dengan sinar-X dada. Keberkesanan proses perlekatan pleura dinilai berdasarkan 
kepada keputusan sinar-X dada. Rawatan dikategorikan sebagai berjaya (‘success’) sekiranya 
imej sinar-X dada tidak menunjukkan pertambahan cecair di antara pleura. Rawatan 
dikategorikan sebagai separuh berjaya (‘partial success’) sekiranya imej sinar-X dada 
menunjukkan pertambahan cecair tetapi pesakit tidak memerlukan rawatan untuk 
mengeluarkan cecair dari ruang pleura. Pesakit yang tidak memenuhi kriteria di atas dikira 
sebagai tidak berjaya (‘failed’). Lima pesakit yang menghidap penyakit malignant pleural 
effusion dari Hospital Universiti Sains Malaysia dan Hospital Raja Perempuan Zainab II 
terlibat dalam kajian prospektif ini. Purata umur pesakit yang terlibat adalah 53.6 tahun and 
purata masa yang diperlukan untuk menamatkan proses perlekatan pleura adalah 9.5 jam. 
Antara penyakit primer yang dihidapi oleh pesakit-pesakit yang terlibat adalah kanser ovari, 
kanser payu dara dan kanser usus. Daripada 5 pesakit yang terlibat, tiga pesakit (60%) 
x 
 
dikategorikan sebagai berjaya, satu pesakit (20%) dikategorikan sebagai separuh berjaya dan 
satu pesakit (20%) dikategorikan sebagai tidak berjaya selepas proses perlekatan pleura 
dilakukan. 
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ABSTRACT 
 
Pleural drainage is the treatment of choice for patients presented with symptomatic malignant 
pleural effusion. The conventional method of treatment is insertion of large bore 
thoracostomy tube (chest tube) before proceeding to chemical pleurodesis. The aim of this 
preliminary prospective study was to investigate the success rate of performing pleurodesis 
using a small bore pigtail catheter (Mar Flow® CH12) in patients with malignant pleural 
effusion. Pleurodesis was performed within twenty four hours after insertion of pigtail 
catheter with bleomycin as sclerosing agent. Patients were follow-up at four weeks post 
pleurodesis with chest radiography. The intervention was scored as “successful” if no 
radiographic evidence of fluid reaccumulation was noted at four weeks. A “partial success” 
score indicated accumulation of fluid that did not produce symptoms and did not require 
repeat pleural drainage of any sort. All other outcomes were scored as “unsuccessful”. Five 
patients with malignant pleural effusion from Hospital Universiti Sains Malaysia and 
Hospital Raja Perempuan Zainab II were included in this study with mean age of 53.6 year 
old. The primary diseases include breast, lung, ovarian and colon cancers. The mean time of 
pleurodesis was 9.5 hours. Of the five pleurodesis performed, a complete response 
(“successful”) was seen in three patients (60%), a partial response (“partial success”) was 
seen in one patient (20%) and one patient (20%) did not respond to rapid pleurodesis. In 
conclusion, pleurodesis in patients with malignant pleurodesis can be achieved rapidly using 
small bore pigtail catheter and bleomycin. 
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1. INTRODUCTION 
 
Malignant pleural effusions (MPEs) are a common complication of advanced 
malignancies, particularly lung and breast cancer. Lung cancer and breast cancer 
account approximately seventy five percents of malignant pleural effusions with the 
remaining twenty five percents representing the cross section of neoplastic disease. The 
collection of pleural fluids in the pleural space results in significant reduction in lung 
vital capacity, hence causing dyspnoea and reduction in quality of life (Lynch Jr, 1993). 
Treatment goals for these patients should focus on symptomatic relief or elimination of 
hospitalization, and efficient use of medical care resources (Antunes and Neville, 2000). 
While malignant pleural effusion is often a sign of advanced and progressive cancer, 
many patients with malignant pleural effusion survive in excess of six months. 
Furthermore, some patients with malignant pleural effusion such as lymphoma and 
germ cell tumours can be cured of their malignancy. Thus, control of malignant pleural 
effusion in a manner which promptly relieves symptoms and maintains quality of life is 
an important part of the overall management of patients with advanced cancer (Lynch 
Jr, 1993). The purpose of this study was to determine the successful rate of rapid 
pleurodesis using small bore pigtail catheter and bleomycin. There were 5 patients with 
malignant pleural effusion involved in this case series. 
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1.1 Pathophysiology 
 
Pleural effusions occur between two membranes: the visceral (inner) layer of the pleura 
attached to the lungs, and the parietal (outer) layer attached to the chest wall. The 
‘‘pleural space’’ normally is nonexistent and is lubricated by a slight amount of pleural 
fluid (10–20 cc) that provides lubrication between the pleura. Fluid (sera) continuously 
moves from the parietal pleura through the pleural space to be absorbed by the visceral 
pleura. The fluid is then drained into the lymphatic system. In patients with primary 
malignancies, metastasis to the pleural space may cause significant shifts or fluid 
imbalance from derangements in the Starling forces that regulate the re-absorption of 
fluid within the pleural space. Movement of pleural fluid across the pleural space may 
involve over 5 to 10 liters per day, and derangements in this movement may increase 
the normal amount of pleural fluid from 5 to 50 cc to a more significant amount. Other 
disease processes may also significantly affect the ability of the body to manage its 
intra-pleural fluid (Putnam Jr, 2002).  
 
1.2 Pleurodesis 
 
Pleurodesis is a treatment that aims to produce fibrosis of the pleura by chemical or 
mechanical means in order to obliterate the pleural space (Shaw and Agarwal, 2004). 
The principle behind this approach is that the chest tube drains the pleural space and the 
sclerosing agent creates a pleuritis that joins the visceral and parietal pleura and prevent 
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fluid re-accumulation (Lynch Jr, 1993). Hence, to avoid the need for repeated 
hospitalization for thoracocentesis. Different techniques have been used over the past 
twenty years with the most commonly used methods employ a chemical sclerosant 
(irritant) which is instilled in the pleural space either during thoracoscopy or bedside 
thoracostomy, following complete drainage of the effusion (Shaw and Agarwal, 2004).  
 
A number of different methods have been used for pleural fluid drainage or evacuation 
and these include thoracocentesis, tube thoracostomy (chest tube), pleuroperitoneal 
shunting and recently the use of small bore catheters. The most common technique 
involves the large bore chest tube drainage followed by chemical pleurodesis with 
various agents. This technique entails significant morbidity including prolonged 
inpatient hospitalization, limited mobility from the pleural drainage apparatus, fevers 
from pleural inflammation and significant pain from chest tube and surgical incision 
(Musani et al., 2004). The principle behind this approach is that the chest tube drains 
the pleural fluid and the sclerosing agent creates a pleuritis that joins the visceral and 
parietal pleura and prevent fluid re-accumulation (Lynch Jr, 1993).  
 
1.3 Sclerosing Agents 
 
Effective sclerosing agents share the property of causing a chemical pleuritis. Although 
many anti-tumour agents have been used successfully as sclerosing agents, it appears 
that the mechanism of control of effusion is related to their ability to induce a pleuritis 
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rather than their anti-tumour activity (Lynch Jr, 1993). Various sclerosant agents have 
been used to achieve pleural symphysis in pleurodesis and these include talc powder, 
bleomycin, tetracycline, quinacrine, silver nitrate and many more. However, the former 
three sclerosing agents mentioned were commonly used. 
 
1.3.1 Tetracycline 
Tetracycline is a low cost, effective therapy that is well tolerated (Lynch Jr, 1993). This 
compound controls effusion in between thirty three and eighty four percents of patients 
treated and it is well distributed throughout the pleural space (Gravelyn et al., 1987, 
Oszko, 1998). The chief side effects of tetracycline sclerosis are fever (33%) and pain 
(41%) (Putnam Jr, 2002).  
 
1.3.2 Talc 
Talc has an efficacy in the eighty percent to more than ninety percent range and a safe 
adverse event profile (Colt and Davoudi, October 2008). Of the more than thirty 
randomized controlled trials comparing different pleurodesis agents, most have favored 
talc, which is recommended pleurodesis agent of choice in the Cochrane Review (Shaw 
and Agarwal, 2004). The major concern with talc is the risk of lung inflammation, 
severe hypoxemia and acute respiratory distress syndrome (Colt and Davoudi, October 
2008). There have also been reports that talc can cause empyema, cardiovascular 
complications such as arrhythmias, cardiac arrest, chest pain, myocardial infarction and 
hypotension (Lynch Jr, 1993). 
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1.3.3 Bleomycin 
Bleomycin is an anti-tumour antibiotic whose efficacy is related to sclerosing action 
rather than anti-neoplastic effects. The standard dose of bleomycin is sixty Units intra-
pleural, with higher doses may be associated with increased toxicity (Lynch Jr, 1993). 
When it is used in this manner, the effectiveness ranges from sixty to eighty percents at 
four weeks (Ostrowski and Halsall, 1982). Side effects of intrapleural bleomycin 
include fever and pain which in a randomized trial, they were similar to tetracycline 
(Lynch Jr, 1993).  
 
1.4 Methods of Pleural Drainage 
 
A number of different methods have been used for pleural fluid drainage or evacuation 
and these include thoracocentesis, tube thoracostomy (chest tube), pleuroperitoneal 
shunting and recently the use of small bore catheters. The most common technique 
involves the large bore chest tube drainage followed by chemical pleurodesis with 
various agents. This technique entails significant morbidity including prolonged 
inpatient hospitalization, limited mobility from the pleural drainage apparatus, fevers 
from pleural inflammation and significant pain from chest tube and surgical incision 
(Musani et al., 2004) 
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1.4.1 Thoracocentesis 
Thoracocentesis plays an important step in diagnosing and managing malignant pleural 
effusion. The wisdom of repeated therapeutic thoracocentesis can and should be 
questioned as symptomatic relief is temporary before the pleural fluid re-accumulate. 
Thoracocentesis alone was associated with a mean time of effusion recurrence of 4.2 
days with the majority recurring in one to three days (Anderson et al., 1974). Repeated 
thoracocentesis increases the risks of pneumothorax, empyema and pleural fluid 
loculation. Therapeutic thoracocentesis should thus be reserved for patients who have 
highly responsive underlying malignancy and will be undergoing chemotherapy or for 
patients who are severely dyspnoeic with life expectancy of less than one month (Lynch 
Jr, 1993).  
 
1.4.2 Tube Thoracostomy (Chest Tube) 
The most common method to drain malignant pleural effusion has been large bore chest 
tube drainage (Sahin et al., 2001). This method entails significant morbidity including 
prolonged inpatient hospitalization, limited mobility from the pleural drainage 
apparatus, fevers from pleural inflammation and significant pain from chest tube and 
surgical incision (Musani et al., 2004). Since many patients with malignant pleural 
effusions have already experienced significant morbidity from chemotherapy and or 
radiation therapy, it would be ideal to minimize hospitalization and patients discomfort 
in the process of relieving respiratory symptoms and controlling fluid re-accumulation 
(Sahin et al., 2001). 
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1.4.3 Pleuroperitoneal Shunting 
The placement of a pleuroperitoneal shunt is an alternative approach that has particular 
appeal in patients with refractory effusions (Tsang et al., 1990). In this approach, a 
catheter is placed subcutaneously into the pleural and peritoneal spaces. A pump is 
manually compressed to drain fluid from the pleura into the peritoneal cavity. This 
approach may also aid patients when the lung is 'trapped' and unable to re-expand to 
allow effective sclerosis. Tumor seeding of the peritoneum is less likely to be a major 
issue in patients who have such advanced malignancy (Lynch Jr, 1993).  
 
1.4.4 Small Bore Catheter 
The use of small bore catheter in achieving pleural drainage has been found to be as 
effective as the large bore catheter. Placement of the large bore chest tube is a surgical 
procedure that requires blunt dissection often resulting in pain and discomfort during 
both placement and maintenance of the tube. In a prospective randomized study, it was 
concluded that pleurodesis in patients with recurrent malignant pleural effusion can be 
performed with a small percutaneous catheter with an effect to that obtained with a 
large bore chest tube and with less discomfort for the patient (Clementsen et al., 1998).  
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1.5 Rapid Pleurodesis 
 
The typical duration of hospitalization for chemical pleurodesis is five to seven days .
 
Much of this time is a consequences of prolonged chest tube drainage both prior to and 
immediately following pleurodesis. The primary goal of drainage prior to pleurodesis is 
to remove sufficient pleural fluid to oppose the pleural surfaces. Some clinicians delay 
pleurodesis until the rate of chest tube drainage is minimal over twenty four hours, 
based on the hypothesis that abundant fluid production reduces the efficacy of 
pleurodesis (Spiegler et al., 2003). 
 
The issue of rapid pleurodesis previously has been investigated. Villanueva et al (1994) 
were able to shorten the duration of chest tube drainage to an average of two days with 
no effect on response to pleurodesis. Spiegler et al (2003) have shown that pleurodesis 
can be accomplished within twenty four hours, and in many cases on the same day. 
Furthermore, the success of pleurodesis was accomplished with a small bore catheter. 
 
In this prospective study, small bore pigtail catheters (Mar Flow
®
 CH12) were used as 
an alternative for conventional thoracostomy tube (chest tube). This catheter is stronger 
and comes in with a trocar which is useful during insertion into the pleural space. The 
use of this pigtail catheter for pleural drainage in malignant pleural effusion has never 
been studied previously. 
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2. OBJECTIVE 
 
The objective of this study was to determine the outcome of rapid pleurodesis using 
small bore pigtail catheter and bleomycin at four weeks follow up appointment. The 
outcome was determined by comparing chest radiography performed before rapid 
pleurodesis with chest radiography performed at four weeks post rapid pleurodesis. 
Outcome will be divided into three categories: 
1. Success procedure when chest radiography at four weeks follow-up 
shows no accumulation of pleural fluid. 
2. Partial success procedure when chest radiography at four weeks follow-
up shows small amount of pleural fluid accumulation but patient is 
asymptomatic and did not require repeat pleural drainage. 
3. Failed procedure when chest radiography at four weeks follow-up shows 
re-accumulation of fluid causing symptoms and the need for repeat 
pleural drainage. 
 
 
 
 
 
 
10 
 
3. PREVIOUS STUDIES 
 
There were few studies that have been done to look for the successful of rapid 
pleurodesis in malignant pleural effusion and also the used of smaller thoracostomy 
tubes and the findings were as below: 
 
a) A rapid pleurodesis provide shorter hospital stay resulting in superior cost 
effectiveness and palliation without sacrificing the effectiveness of pleurodesis. 
In this prospective randomized study by Yildrim et al (2005), a comparison was 
made between rapid pleurodesis using small bore catheter (size 12 Fr) with 
standard protocol. In this study, rapid pleurodesis is performed by aspirating the 
pleural fluid at six hour intervals with instillation of oxytetracycline after each 
aspiration. They concluded that this new pleurodesis method provided shorter 
hospital stay resulting in superior cost-effectiveness and palliation without 
sacrificing the efficacy of pleurodesis. However, the range of drainage time was 
between 1.5 to 4.5 days.  
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b) Chemical pleurodesis can be accomplished with good results in less than twenty 
four hours in majority of patients with malignant pleural effusions. In this study 
by Spiegler et al (2003), a small size thoracostomy tube (size 14 Fr) has been 
used to drain pleural effusion and chemical pleurodesis was performed using 
either bleomycin or talc two hours post pleural drainage. Of the twenty nine 
patients included in this study, twenty three patients (79%) did not require 
further intervention in subsequent follow-up. 
 
c) In another prospective randomized study, a comparison was made between 
Cystofix
®
 catheter size CH10 and conventional large bore chest tube size CH24. 
It was concluded that pleurodesis in patients with recurrent malignant pleural 
effusion can be performed with a small percutaneous catheter with an effect to 
that obtained with a large bore chest tube and with less discomfort for the patient 
(Clementsen et al., 1998).  
 
d) Parker, et al (1989) compared the drainage of pleural effusion using 
nephrostomy tube size 8.3 Fr or 10 Fr with conventional chest tube size 32 to 38 
Fr. The aim of this study is to determine the effectiveness of the pleural drainage 
using small bore catheter. They concluded that percutaneous placement of small 
bore catheter appear to be adequate for the drainage of many malignant pleural 
effusion with less pain and better tolerated once the catheter is in place.  
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Based on the previous study results, it can be hypothesized that effective pleurodesis 
can be accomplished rapidly (within twenty four hours) using small bore catheter and 
bleomycin as sclerosing agent in patients with malignant pleural effusion. 
 
4. MATERIAL AND METHODS 
 
4.1 Study Design 
This was a preliminary prospective study done at Hospital Universiti Sains Malaysia, 
Kubang Kerian and Hospital Raja Perempuan Zainab II, Kota Bharu with the 
involvement of Cardiothoracic, General Surgery, Orthopaedic (OORU), Oncology, 
Obstetric and Gynaecology and Radiology Units. The principle protocol of this study 
has been approved by Research Ethics Committee (Human), Universiti Sains Malaysia. 
This was a twelve month period study involving patients with malignant pleural 
effusion. Based on the single proportion formula, 138 subjects were needed for this 
preliminary prospective study. However, due to the small number of patients involved 
in this study, the initial prospective study has to be converted into case series study. 
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4.2 Subjects 
There were five patients with malignant pleural effusions involved in this study. All 
patients have primary malignancy that have been diagnosed either by clinical 
presentation which was supported by radiological investigations or by tissue diagnoses 
before participating in this study. All patients were diagnosed with malignant pleural 
effusion based on clinical presentation of dyspnoea and supported by chest radiography. 
To prevent bias, the decision to include the subjects for this study and the insertion of 
pigtail catheter were made by medical officers who were not involved in this study.  
 
4.3 Methods 
Informed consent was taken before proceeding to insertion of the small bore pigtail 
catheter. A small bore pigtail catheter size 12 Fr (Figure 19) was inserted under aseptic 
technique and open method. All patients were given intravenous sedation with 5 
milligrams of Midazolam prior to procedure. A local anaesthetic agent with 10 
milliliters of 2% Lignocaine without adrenaline was given at the incision site. A two 
centimeters incision was made on the skin in the safety triangle (border of pectoralis 
major, latissimus dorsi and fifth intercostal space or at nipple line) and the wound 
deepened until intercostals space. An 18-gauge needle connected to a syringe was 
introduced (Figure 20). While aspirating, the needle was pushed until the effusion is 
freely aspirated. Using the 18-gauge needle as a landmark, a floppy tipped guide wire 
with a tapered mandril was inserted into the pleural space (Figure 20). The 18-gauge 
needle was then removed and using a vascular dilator (Figure 20), the tract was dilated 
and a 12 Fr pigtail catheter was introduced. Once the pigtail catheter was in place, the 
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floppy guide wire was removed. The pigtail catheter was anchored to the skin using Silk 
0 suture. The drainage of pleural fluid began with pigtail catheter connected to low 
pressure suction at negative 20 cm H2O (Figure 21). 
 
All patients had a plain chest radiograph taken post procedure to assess the site of the 
pigtail catheter and also to assess any immediate complication that needs intervention. 
Sample of pleural fluid was taken and sent for biochemistry and cytology analysis. 
Drainage of the pleural fluid was continued for two hours. Drainage was withheld if the 
amount reached 1.5 liters before the 2-hour period. 
 
Prior to instillation of Bleomycin, all patients received 10 milliliters of 2% Lignocaine 
injected into pleural space. Sixty units of Bleomycin diluted in 50 milliliters of Normal 
Saline were then instilled into the pleural space. The pigtail catheter was clamped for 
ninety minutes after instillation of Bleomycin. No change in position technique to 
equally distributed Bleomycin was adopted post instillation of the drug. The pigtail 
catheter was unclamped and the drainage was continued for another two hours before 
the catheter was removed. The pleurodesis process was carried out in spite of the 
amount of pleural fluid drained. The removal of pigtail catheter was also independent of 
the pleural fluid amount drained after instillation of bleomycin. 
 
 
 
15 
 
Post removal of pigtail catheter, chest radiography was performed for assessment. 
Patients were followed-up at four weeks period with repeat chest radiography. All chest 
radiographs were reviewed by radiologist. The success of the study was based on chest 
radiography findings and also patients’ symptoms. The procedure was considered as 
success if the chest radiography at four weeks follow-up showed no accumulation of 
pleural fluid. Partial success was considered if the chest radiography at follow up 
showed small amount of pleural fluid accumulation but patient was asymptomatic. The 
procedure was considered fail if chest radiography showed re-accumulation of fluid 
causing symptoms and the need for repeated pleural drainage.  
 
4.4 Inclusion and Exclusion Criteria 
 
Patients with primary malignancy that presented with symptoms of dyspnoea and chest 
radiograph showed accumulation of pleural fluid malignant were included in this study. 
These patients were considered to have malignant pleural effusion. All patients who 
participated in this study were consented. Subjects were excluded from this study if 
blood was drained from pleural space after pigtail catheter was inserted, patient who 
died before the follow-up period, patients who developed complications post procedure 
that requires bigger drainage apparatus (tube thoracostomy), patients who had multiple 
pleurodesis performed prior to participating in this study and patients who refused 
informed consent. 
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5. CASE SERIES 
Case 1 
 
This patient was a 63 year old Chinese lady who was a known case of right breast 
cancer with advanced disease. Right mastectomy with axillary clearance was performed 
in 2007 and patient completed chemotherapy and radiotherapy. A CT scan abdomen and 
thorax performed six months after completed treatment showed distant metastases to 
liver and also lung. Patient was admitted to surgical ward under neurosurgical team with 
history of reduced in GCS associated with altered sensorium and right hemiparesis. 
Computer tomographic scan (Figure 4) and MRI of the brain (Figure 5) showed 
multiple lesions suggestive of brain metastases. Patient also had symptom of dyspnoea 
and CXR revealed right pleural effusion (Figure 6). Rapid pleurodesis was performed 
according to the protocol proposed. The procedure completed after 6 hours. Immediate 
post pleurodesis CXR showed improvement with aeration over the affected area. Patient 
was seen again in the clinic 4 weeks after pleurodesis with CXR showed no 
accumulation of pleural effusion and patient was asymptomatic (Figure 7). The pleural 
fluid biochemistry analysis and cytology came back as pH of 7.5 and no malignant cells 
seen. 
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Figure 1 – CT scan brain showed heterogeneously enhanced lesions with perilesional 
edema seen in the left centrum semiovale. 
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Figure 2 – MRI brain showed heterogeneously enhanced lesion with perilesional edema 
seen, hyperintense on T2 image. 
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Figure 3 – Pre-insertion of pigtail catheter and pleurodesis CXR showed right opacity 
right lung suggestive of pleural effusion. 
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Figure 4 – Four weeks post pleurodesis CXR showed aeration of the right lung. 
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Case 2 
 
This patient was a 38 year old Malay gentleman who presented to HUSM with 
symptoms of headache associated with left hemiparesis of 1 month duration. The 
symptoms were progressive and patient was unable to mobilize without any assistant. 
Patient was admitted under Neurosurgical team for further investigation. A CT scan of 
brain and thorax (Figure 8) performed showed perihilar mass over the right lung with 
massive pleural effusion and multiple brain lesions which suggestive of lung cancer as a 
primary pathology with brain metastasis. Patient also had dypsnoea at rest. Patient was 
consulted and agreed for pleurodesis. Rapid pleurodesis was performed according to 
protocol suggested. The procedure was performed in late afternoon and CXR post 
insertion of pigtail catheter was only done at midnight. The decision not to proceed with 
pleurodesis after midnight was made and thus, the drainage of pleural fluid was 
continued until morning. Pleurodesis was only performed at 10 o’clock the next 
morning. The whole procedure was completed after 18 hours. Immediate post 
pleurodesis CXR showed improvement with aeration over the upper and middle zones 
of the right lung (Figure 9). The symptom of dyspnoea was slightly improved and 
patient was discharged home 2 weeks after admission. Patient was again admitted to 
HUSM with symptom of seizure at home and dyspnoea was getting worse. A CXR on 
second admission (3 ½ weeks post pleurodesis) showed reaccumulation of pleural 
effusion (Figure 10) and large bore chest thoracostomy had to be inserted in view of the 
CXR finding and also symptom of dyspnoea. Pleural fluid analysis for biochemistry and 
cytology came back as pH of 6.9 and malignant cells seen. 
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Figure 5 – CT thorax showed right pleural effusion with thickening of pleura and 
atelectasis of right middle lobe. 
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Figure 6 – Immediate CXR post pleurodesis showed aeration of the right upper and 
middle zones. 
 
 
 
 
 
 
 
24 
 
 
Figure 7 – CXR at 3 ½ weeks after pleurodesis showed reaccumulation of pleural 
effusion of right lung. 
 
 
 
 
 
 
 
    
